Wealth Awesome
TSX closed
Loading markets…
PARTNER SPOTLIGHT
CIBC Investor's Edge

Buy the stocks you believe in, for less

For a limited time, trade fractional shares commission-free.¹

  • ✓Own a piece of your favourite companies without buying an entire share
  • ✓Stocks and ETFs, from as little as $1
  • ✓In any account: TFSA, FHSA, RRSP and more

¹Online fractional trades in North American equities under one share, Sep 15, 2026 to Oct 31, 2027. One qualifying order per security, per side, per day. Conditions apply.

Stocks/NASDAQ/XCUR

Exicure Inc (XCUR : NASDAQ)

$1.08USD+0.19 (21.31%)Close of 2026-11-10

Common Stock

Follow XCUR

XCUR

Exicure Inc

Source:WealthAwesomeWealthAwesome
↓ $0.11 (-9.24%)
30 day period
$0.89$1.05$1.21Sep 30Oct 21Nov 10

Performance

1 Day

+21.31%

1 Week

+6.93%

1 Month

+2.86%

YTD

-49.77%

The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.

Key Statistics

Market Cap

$7.07M

52W High

$9.48

52W Low

$0.78

P/E Ratio

-

50 Day MA

$1.15

200 Day MA

$2.56

Beta

3.74

Dividend Yield

-

Performance history

XCUR returns since 2026

Exicure Inc has traded since Jun 2026 in our data. Its deepest fall was −67.5% (Jun 2026 to Nov 2026).

1 year / yr

—

3 years / yr

—

5 years / yr

—

10 years / yr

—

Calendar-year returns

  • 2026*−49.8%

* Partial year (first year of data, or year to date).

$10,000 invested in XCUR

  • 2026 (start of our data)$5,023
All-time high in our data
$3 on Jun 22, 2026 · now −60.6%

Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Jun 2026 to Nov 2026. Past returns do not predict future ones.

Awesome Portfolio™

Looking past XCUR? Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/10/2026$0.92$1.19$0.78$1.08$1.08895,699
11/9/2026$0.95$0.95$0.86$0.89$0.8938,938
11/6/2026$0.89$0.95$0.86$0.95$0.9517,700
11/5/2026$0.91$0.95$0.89$0.89$0.8924,154
11/4/2026$0.97$1.00$0.89$0.99$0.9918,500
11/3/2026$1.01$1.03$1.00$1.01$1.0115,858
11/2/2026$1.03$1.06$0.97$1.02$1.0231,356
10/30/2026$0.94$1.06$0.94$1.01$1.0129,600
10/29/2026$1.05$1.09$0.90$0.93$0.9341,350
10/28/2026$1.08$1.13$1.01$1.02$1.0224,691

Analyst Price Targets

Based on analyst covering XCUR · as of Oct 5, 2026

📈

Wall Street analysts forecast XCUR stock price to rise 85.2% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

US$2.00

+85.2% Upside

Current Price

US$1.08

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on XCUR's historical volatility

HistoricalForecast68%95%
US$0.25US$0.86US$1.46US$2.07US$2.68US$3.29TodayJul 6Sep 8Nov 10Dec 23Feb 5Mar 20

30-Day Vol

105.6%

Annualized

90-Day Vol

96.3%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

US$0.90

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$1.02US$0.71 – US$1.46
60 trading daysUS$0.96US$0.57 – US$1.61
90 trading daysUS$0.90US$0.48 – US$1.70

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Exicure Inc

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.

Financials

Revenue (TTM)
$0
EBITDA
$-7.11M
Profit Margin
0.00%
ROE (TTM)
-168.37%
EPS (Diluted)
-1.31
Book Value
0.15

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

Free newsletter

The Saturday TSX Wrap

Saturday morning

The week on the TSX, in five minutes

  • The biggest gainers and losers, and why they moved
  • Sector and momentum moves at a glance
  • The Canadian market stories you missed

Free. One email a week. Unsubscribe any time.

Common Questions About XCUR.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
SMXSMX (Security Matters) Public Limited Company Class A Ordinary Shares$19.25+105.88%
PEPGPepGen Ltd$4.61+92.89%
TTECTTEC Holdings Inc$2.40+72.04%
NNOXNano X Imaging Ltd$0.37+59.80%
TANHTantech Holdings Ltd$30.56+58.01%
AACGATA Creativity Global$0.89+52.14%
ESLAEstrella Immunopharma Inc.$0.75+45.40%
MNDOMIND CTI Ltd$1.26+44.83%

Free with a Wealth Awesome account

Keep analysing XCUR, free

  • Every WA Score, ranking and table
  • Insider track records and SEDI filings
  • Earnings history and analyst targets for every stock

Email only, no password, no card. Already a member? Use the same button to sign in.